L Parnetti Selected Research

L Parnetti Research Topics

Disease

19	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 02/2000
9	Dementia (Dementias) 01/2020 - 03/2000
7	Cognitive Dysfunction 01/2020 - 11/2001
7	Stroke (Strokes) 04/2006 - 11/2001
3	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 12/2001 - 02/2000
2	Parkinson Disease (Parkinson's Disease) 06/2009 - 01/2007
2	Hyperhomocysteinemia 01/2007 - 04/2004
2	Ischemic Stroke 06/2005 - 01/2000
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2020
1	Amyloid Plaque 02/2012
1	Synucleinopathies 06/2009
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2008
1	CADASIL 11/2008
1	Ischemia 10/2007
1	Seizures (Absence Seizure) 10/2007
1	Embolic Stroke 04/2006
1	Hyperlipidemias (Hyperlipidemia) 06/2005
1	Transient Ischemic Attack 06/2005
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2005
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2002
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2002
1	Vascular Diseases (Vascular Disease) 01/2002
1	Blood Vessel Dissection 01/2002
1	Autoimmune Diseases (Autoimmune Disease) 01/2002
1	Neurobehavioral Manifestations 11/2001
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2001
1	Drug-Related Side Effects and Adverse Reactions 06/2000

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2001
4	AcetylcholinesteraseIBA 08/2011 - 11/2001
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 10/2003
3	ButyrylcholinesteraseIBA 08/2011 - 09/2002
3	amyloid beta-protein (1-42)IBA 11/2008 - 02/2001
3	HomocysteineIBA 01/2007 - 11/2001
3	Cholinergic Agents (Cholinergics)IBA 12/2001 - 11/2001
2	EnzymesIBA 06/2009 - 11/2008
2	tau Proteins (tau Protein)IBA 11/2008 - 09/2002
2	Neuroprotective AgentsIBA 10/2007 - 01/2000
2	AnticoagulantsIBA 04/2006 - 06/2005
2	Amyloid beta-PeptidesIBA 11/2001 - 01/2001
2	Choline (Choline Chloride)IBA 11/2001 - 11/2001
2	Glycerylphosphorylcholine (Choline Alfoscerate)IBA 11/2001 - 11/2001
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020
1	Glucosylceramidase (Glucocerebrosidase)IBA 06/2009
1	beta-MannosidaseIBA 06/2009
1	beta-N-AcetylhexosaminidasesIBA 06/2009
1	beta-Galactosidase (Lactaid)IBA 06/2009
1	alpha-Mannosidase (LAMAN)IBA 06/2009
1	3-nitropropionic acidIBA 10/2007
1	Levetiracetam (Keppra)FDA LinkGeneric 10/2007
1	Glucose (Dextrose)FDA LinkGeneric 10/2007
1	MagnesiumIBA 10/2007
1	Memantine (Namenda)FDA Link 10/2007
1	Oxygen (Dioxygen)IBA 10/2007
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2007
1	N-Methylaspartate (NMDA)IBA 10/2007
1	Levodopa (L Dopa)FDA LinkGeneric 01/2007
1	VitaminsIBA 01/2007
1	Cytidine Triphosphate (CTP)IBA 04/2006
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2005
1	Antiphospholipid AntibodiesIBA 01/2002
1	CollagenIBA 01/2002
1	Cholinergic ReceptorsIBA 12/2001
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2001
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2001
1	PhosphatidylserinesIBA 11/2001
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2001
1	Pharmaceutical PreparationsIBA 11/2001
1	Cytidine Diphosphate Choline (Citicoline)IBA 11/2001
1	Complement System Proteins (Complement)IBA 11/2001
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 11/2001
1	LecithinsIBA 11/2001
1	Dihydroergocryptine (Dihydroergocryptine Mesylate)FDA Link 06/2000
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2000
1	Pyruvic Acid (Pyruvate)IBA 02/2000

Therapy/Procedure

2	Institutionalization (Institutionalized Persons) 01/2017 - 03/2000
1	Stroke Rehabilitation 04/2006
1	Secondary Prevention 04/2006
1	Therapeutics 06/2005